AJP - Heart Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (May 6, 2004). doi:10.1152/ajpheart.00629.2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/3/H1225    most recent
00629.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Monti, L. D.
Right arrow Articles by Fazio, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Monti, L. D.
Right arrow Articles by Fazio, F.
Submitted on July 3, 2003
Accepted on April 9, 2004

MYOCARDIAL INSULIN RESISTANCE ASSOCIATED WITH CHRONIC HYPERTRIGLYCERIDEMIA AND INCREASED FFA LEVELS IN TYPE 2 DIABETIC PATIENTS

Lucilla D. Monti1*, Claudio Landoni2, Emanuela Setola3, Elena Galluccio1, Pietro Lucotti3, Emilia P. Sandoli1, Anna Origgi3, Giovanni Lucignani4, PierMarco Piatti3, and Ferruccio Fazio2

1 Lab L20,Core Lab, Diabetology, Endocrinology and Metabolic Disease Unit, Medicine Division, IRCCS H. San Raffaele, Milan, Italy
2 Division of Nuclear Medicine, IRCCS H. San Raffaele, Milan, Italy
3 Cardiovascular and Metabolic Rehabilitation Unit, IRCCS H. San Raffaele, Milan, Italy
4 Imaging and Radiotherapy Unit, University of Milan, Milan, Italy

* To whom correspondence should be addressed. E-mail: lucilla.monti{at}hsr.it.

The aim of this study was to evaluate the influence of chronic hypertriglyceridemia and endothelial dysfunction on myocardial glucose uptake (MGU) in type 2 diabetic patients in the absence of CHD. A cross-sectional study was conducted in sixteen patients with type 2 diabetes, with a negative history of cardiovascular disease, normal heart rate and normal resting ECG and M-mode and two-dimensional echocardiogram, were recruited from the outpatient diabetic clinic. Myocardial glucose uptake was assessed by using [18F]-2-fluoro-2-deoxy-D-glucose ([18F]FDG) under hyperglycemic hyperinsulinemic conditions. The patients were divided into two groups according with fasting triglyceride levels (High TG 5.4±1.1 mmol/l vs Normal TG 1.5±0.3 mmol/l). Five subjects pertained to the High TG group while 11 subjects were allocated into the Normal TG group. Age, gender, BMI, systolic and diastolic blood pressure, glucose, insulin, HbA1c, cholesterol and HDL cholesterol were similar in the two groups, while FFA levels were higher in the high TG group basally and at the end of the clamp. Furthermore, five healthy sujects were submitted to the same protocol as Controls group. Basal ET-1 and NOx levels were significantly higher while cGMP and maximal post-ischemic vasodilation were significantly decreased in High TG group than in the other two groups. However, significant alterations were found in the same parameters in the Normal TG group compared with Controls group. By the end of the hyperglycemic clamp, in High TG group, MGU was about 40% and 65% those obtained in Normal TG and Controls groups, respectively and M/I ratio, index of whole body insulin sensitivity, was decreased by 50% and 65%, respectively. MGU negatively correlated with triglyceride, FFA and ET-1 while a positive correlation was found with cGMP and maximal post-ischemic vasodilation. A positive correlation was also found between M/I and cGMP and between M/I and MGU. The present study demonstrated that increased TG and FFA levels are additional risks, in addition to type 2 diabetes mellitus, for myocardial insulin resistance associated with endothelial dysfunction and alteration of nitric oxide/cGMP levels.




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
N. Yang, C. Ying, M. Xu, X. Zuo, X. Ye, L. Liu, Y. Nara, and X. Sun
High-fat diet up-regulates caveolin-1 expression in aorta of diet-induced obese but not in diet-resistant rats
Cardiovasc Res, October 1, 2007; 76(1): 167 - 174.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. An and B. Rodrigues
Role of changes in cardiac metabolism in development of diabetic cardiomyopathy
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1489 - H1506.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
N. D. Oakes, P. Thalen, E. Aasum, A. Edgley, T. Larsen, S. M. Furler, B. Ljung, and D. Severson
Cardiac metabolism in mice: tracer method developments and in vivo application revealing profound metabolic inflexibility in diabetes
Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E870 - E881.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. D. Monti, E. Setola, G. Fragasso, R. P. Camisasca, P. Lucotti, E. Galluccio, A. Origgi, A. Margonato, and P. Piatti
Metabolic and endothelial effects of trimetazidine on forearm skeletal muscle in patients with type 2 diabetes and ischemic cardiomyopathy
Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E54 - E59.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. Carroll, A. N. Carley, J. R. B. Dyck, and D. L. Severson
Metabolic effects of insulin on cardiomyocytes from control and diabetic db/db mouse hearts
Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E900 - E906.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Berger, D. Monks, H. Schmidt, V. Krane, C. Wanner, U. Walter, and T. H. Lindner
Are Glucokinase Mutations Associated with Low Triglycerides?
Clin. Chem., April 1, 2005; 51(4): 791 - 793.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.